New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 1, 2021, Hikma - Mylan, Glenmark and Camber/Hetero launched AB-rated generic versions of Eisai’s Banzel (rufinamide) 200 mg and 400 mg tablets.
Download PDF
Return to publications
